Arcus Biosciences, Inc. (RCUS)
29.28
+0.07
(+0.24%)
USD |
NYSE |
Aug 31, 16:00
29.24
-0.04
(-0.14%)
Pre-Market: 20:00
Arcus Biosciences Net Income (TTM) : -460.00M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -460.00M |
| March 31, 2026 | -369.00M |
| December 31, 2025 | -353.00M |
| September 30, 2025 | -341.00M |
| June 30, 2025 | -298.00M |
| March 31, 2025 | -391.00M |
| December 31, 2024 | -283.00M |
| September 30, 2024 | -270.00M |
| June 30, 2024 | -249.00M |
| March 31, 2024 | -231.00M |
| December 31, 2023 | -307.00M |
| September 30, 2023 | -293.46M |
| June 30, 2023 | -287.38M |
| March 31, 2023 | -279.01M |
| December 31, 2022 | -267.00M |
| September 30, 2022 | 79.82M |
| June 30, 2022 | 66.77M |
| Date | Value |
|---|---|
| March 31, 2022 | 57.43M |
| December 31, 2021 | 52.83M |
| September 30, 2021 | -278.39M |
| June 30, 2021 | -198.59M |
| March 31, 2021 | -167.70M |
| December 31, 2020 | -122.86M |
| September 30, 2020 | -87.60M |
| June 30, 2020 | -111.78M |
| March 31, 2020 | -94.79M |
| December 31, 2019 | -84.71M |
| September 30, 2019 | -80.41M |
| June 30, 2019 | -68.87M |
| March 31, 2019 | -54.31M |
| December 31, 2018 | -49.59M |
| September 30, 2018 | -50.51M |
| June 30, 2018 | -62.82M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 413.60M |
| AVITA Medical, Inc. | -43.08M |
| Iovance Biotherapeutics, Inc. | -289.52M |
| Editas Medicine, Inc. | -73.95M |
| Recursion Pharmaceuticals, Inc. | -518.88M |